Standout Papers

Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or ... 2016 2026 2019 2022 321
  1. Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence (2016)
    Fred Poordad, Eugene R. Schiff et al. Hepatology

Immediate Impact

1 by Nobel laureates 2 from Science/Nature 72 standout
Sub-graph 1 of 18

Citing Papers

Hepatitis B
2023 Standout
Diagnosis and Management of Cirrhosis and Its Complications
2023 Standout
2 intermediate papers

Works of Eugene Swenson being referenced

Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post‐liver transplantation recurrence
2016 Standout
Prevention of Neonatal Hepatitis B Virus Transmission
2014

Author Peers

Author Last Decade Papers Cites
Eugene Swenson 441 70 417 319 19 1.0k
Markus Keiser 203 65 251 51 36 1.3k
Marina H. de Jager 183 40 116 74 25 1.2k
Karl‐Heinz Schlemmer 259 38 304 26 15 1.3k
M. J. Dew 94 42 336 110 22 891
Clarence L. Young 103 12 127 82 33 857
Pascale Dehertogh 431 13 427 39 19 1.1k
Richard J. Ptachcinski 82 22 170 97 28 1.2k
Martin Senn 129 38 167 33 29 912
Ashutosh Barve 113 96 196 23 25 875
Betty Weert 375 30 282 26 22 885

All Works

Loading papers...

Rankless by CCL
2026